Bank of Montreal
BDTX icon

Bank of Montreal’s Black Diamond Therapeutics BDTX Stock Holding History

Bank of Montreal’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-28,593
Closed -$139K – 3861
2024
Q2 		$139K Buy
+28,593
New +$153K ﹤0.01% 3143
2023
Q3 		– Sell
-15,000
Closed -$76.3K – 3810
2023
Q2 		$76.3K Buy
+15,000
New +$30.6K ﹤0.01% 3511
2021
Q2 		– Sell
-651
Closed -$16K – 3766
2021
Q1 		$16K Sell
651
-2,131
-77% -$57.5K ﹤0.01% 4139
2020
Q4 		$97K Buy
2,782
+1,945
+232% +$63.9K ﹤0.01% 3607
2020
Q3 		$28K Sell
837
-146
-15% -$4.44K ﹤0.01% 3670
2020
Q2 		$35K Buy
+983
New +$36.2K ﹤0.01% 3593

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Bank of Montreal's BDTX Position: Q3 2024 in Review

Bank of Montreal sold out of Black Diamond Therapeutics (BDTX) in Q3 2024, closing a stake of 28,593 shares — an estimated $139K sold.

Bank of Montreal first reported a position in BDTX in Q2 2020 and held it in 6 quarters. The position peaked at $139K in Q2 2024. 96 funds tracked by Wall St. Rank hold BDTX as of Q3 2024.

  • Bank of Montreal reported no remaining Black Diamond Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 28,593 Black Diamond Therapeutics shares in Q3 2024, an estimated $139K.
  • Bank of Montreal first reported a position in Black Diamond Therapeutics in Q2 2020 and held it in 6 quarters.
  • Bank of Montreal's Black Diamond Therapeutics position peaked at $139K in Q2 2024.
  • 96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.